The protein levels of GPX4, SLC7A11, and SLC3A2 decreased following BBR treatment in a dose-dependent manner in S18 and 5-8F NPC cells (Fig. 6A). This evidence concerns the gene SLC3A2 and nasopharyngeal carcinoma.